These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3314969)

  • 1. Beta 2 microglobulin expression in keratoacanthomas and squamous cell carcinoma.
    Graham RM; MacFarlane AW; Curley RK; Nash JR
    Br J Dermatol; 1987 Oct; 117(4):441-9. PubMed ID: 3314969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30+ cells in regressing keratoacanthoma and in non-keratoacanthomatous squamous cell carcinoma.
    Fernandez-Flores A
    Bratisl Lek Listy; 2008; 109(11):508-12. PubMed ID: 19205562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid dendritic cell involvement in the host response against keratoacanthoma.
    Abbas O; Hussein L; Kurban M; Kibbi AG
    J Am Acad Dermatol; 2014 Jun; 70(6):1142-5. PubMed ID: 24831321
    [No Abstract]   [Full Text] [Related]  

  • 6. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
    Markey AC; Churchill LJ; MacDonald DM
    J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal antigens in experimental keratoacanthoma and squamous cell carcinoma.
    Muller HK; Flannery GR
    Cancer Res; 1973 Sep; 33(9):2181-6. PubMed ID: 4579775
    [No Abstract]   [Full Text] [Related]  

  • 8. H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin.
    Ariano MC; Wiley EL; Ariano L; Coon JS; Tetzlaff L
    J Dermatol Surg Oncol; 1985 Nov; 11(11):1076-83. PubMed ID: 3902925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1).
    Matsuta M; Kimura S; Kosegawa G; Kon S; Matsuta M
    J Dermatol; 1996 Mar; 23(3):147-52. PubMed ID: 8935623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of an antisquamous antibody in multiple keratoacanthoma.
    Ahmed AR; Sofen H; Saxon A
    Clin Immunol Immunopathol; 1982 Jan; 22(1):20-31. PubMed ID: 6749353
    [No Abstract]   [Full Text] [Related]  

  • 11. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas.
    Jensen P; Clausen OP; Bryne M
    J Cutan Pathol; 1999 Apr; 26(4):183-9. PubMed ID: 10335895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Another contribution to the problem of keratoacanthomas].
    Maggiora A
    Dermatologica; 1968; 137(4):2639. PubMed ID: 5685903
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleolar organizer region enumeration in keratoacanthomas and squamous cell carcinomas of the skin.
    Kanitakis J; Hoyo E; Hermier C; Chouvet B; Thivolet J
    Cancer; 1992 Jun; 69(12):2937-41. PubMed ID: 1591687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Differential Immunoexpression of Inhibitory Immune Checkpoint Molecules and Clinicopathological Correlates in Keratoacanthoma, Primary Cutaneous Squamous Cell Carcinoma and Metastases.
    Lonsdorf AS
    Acta Derm Venereol; 2024 Sep; 104():. PubMed ID: 39233466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
    Cheville JC; Bromley C; Argenyi ZB
    J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle-associated antigen in experimental cutaneous squamous cell carcinoma, keratoacanthoma, and papilloma.
    Toh BH; Muller HK
    Cancer Res; 1975 Dec; 35(12):3741-5. PubMed ID: 811354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and beta 2-microglobulin expression in basal and squamous cell carcinomas of the skin.
    Hua LA; Kagen CN; Carpenter RJ; Goltz RW
    Int J Dermatol; 1985 Dec; 24(10):660-3. PubMed ID: 3910595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
    Asch PH; Basset P; Roos M; Grosshans E; Bellocq JP; Cribier B
    Am J Dermatopathol; 1999 Apr; 21(2):146-50. PubMed ID: 10218674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
    Beham A; Regauer S; Soyer HP; Beham-Schmid C
    Adv Anat Pathol; 1998 Sep; 5(5):269-80. PubMed ID: 10021894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.